ÇѸ²´ëÇб³¼º½Éº´¿ø

±èÈ£¿µ ±³¼ö

031-380-3704 ksfamily@hallym.or.kr
  • Àü¹®¼¾ÅÍ À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍ
  • Áø·á°ú Ç÷¾×Á¾¾ç³»°ú

Àü¹®Áø·áºÐ¾ß

À¯¹æ¾Ï ¹× Æó¾Ï, ºñ´¢±â/ºÎÀΰúÁ¾¾ç, ¾Ç¼ºÈæ»öÁ¾ ¹× À°Á¾, ÇǺξÏ, ÀÏ¹Ý Ç÷¾×Áúȯ(°ñ¼öÁõ½Ä¼ºÁúȯ, ºóÇ÷ ¹× Ç÷¼ÒÆÇ Áúȯ µî)

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2022-08-15 ~ 2022-08-20)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·áÈÞÁø
¿ÀÈÄ ¼¾ÅÍÁø·á¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

¿¬¼¼´ëÇб³ ¿øÁÖÄ·ÆÛ½º Àǰú´ëÇÐ Á¹¾÷

¾ÆÁÖ´ëÇб³ Àǰú´ëÇÐ ¼®»ç

¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

°æ·Â

°æ·Â

»ï¼º¼­¿ïº´¿ø ¿¬±¸°­»ç

Çö) ÇѸ²´ëÇб³¼º½Éº´¿ø Ç÷¾×Á¾¾ç³»°ú ±³¼ö

¿¬¼¼´ëÇб³ ¿øÁÖÄ·ÆÛ½º Àǰú´ëÇÐ Á¶±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑÇ÷¾×ÇÐȸ Á¤È¸¿ø

´ëÇÑÁ¾¾ç³»°úÇÐȸ Á¤È¸¿ø

´ëÇѾÏÇÐȸ Á¤È¸¿ø

³í¹®

Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients (Chemotherapy)

Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13) (CYTOKINE)

Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients (Tuberculosis and Respiratory Diseases)

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms (The Korean Journal of Internal Medicine)

A Novel Pathogenic CALR Exon 9 Mutation in a Patient with Essential Thrombocythemia (LABORATORY MEDICINE)

Novel genes exhibiting DNA methylation alterations in Korean patients with chronic lymphocytic leukaemia: a methyl-CpG-binding domain sequencing study (SCIENTIFIC REPORTS)

BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis (Pathology Research and Practice)

First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea (Annals of Laboratory Medicine)

Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus$$cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective$$analysis: KCSG GU 17-03 (Cancer Med)

Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive$$lung cancer: Comparison with EGFR-mutated lung cancer (Pathol Res Pract)